A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Status:
ENROLLING_BY_INVITATION
Trial end date:
2028-01-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect long-term safety data in participants with cancers including acute myeloid leukemia, non-Hodgkin lymphoma, myelodysplastic syndrome, chronic lymphocytic leukemia (type of cancer of the blood and bone marrow in which the bone marrow makes a large number of abnormal blood cells) and advanced solid tumors and metastatic castration-resistant prostate cancer (mCRPC).